Text Only Version A A A

BPAS comment on new embryology study published in Nature

Marta Jansa Perez, Director of Embryology at BPAS, said:

“Some research really does move our understanding of embryo development forward. This fascinating study by Kathy Niakan’s group is one such example.

“The team has shown that in human embryos the first lineage differentiation event occurs at the morula stage of embryo development. They demonstrate that at this stage the outer cells of the embryo initiate the molecular process of placenta formation. Understanding the initial steps of placental cells differentiation is crucial, since problems in placental function like placental insufficiency can affect the development of the foetus and lead to problems later on in pregnancy. These exciting findings are very relevant to our understanding of early human embryo development and placenta formation, and have the potential to lead to improvements in fertility treatments in the future.”


The study can be accessed at https://doi.org/10.1038/s41586-020-2759-x

For further information please contact BPAS on press@bpas.org or 07788 725185

About BPAS

BPAS is a charity which sees almost 100,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice. BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here: https://www.bpas.org/get-involved/centre-for-reproductive-research-communication/

BPAS intends to launch a not-for-profit fertility service in Spring 2021, to provide ethical, evidence based, person-centred care that supports patients. We intend to only charge what it costs to provide a safe, high-quality, and accessible service to patients who may be unable to access NHS funded care.